StockVS

NYSE · Household & Personal Products · USD

Kenvue Inc. (KVUE) Stock Analysis

Kenvue Inc. (KVUE) is a Household & Personal Products stock listed on NYSE and quoted in US Dollar.

KVUE

$18.74

−$0.21 (−1.11%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare KVUE with… →

KVUE Key Statistics

As of Sep 4, 2026
Trading
Open
$18.85
Previous Close
$18.95
Day's Range
18.69–18.98
52-Week Range
14.02–20.13
Volume
26.86M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.43
Valuation
Market Cap
$36.00B
P/E Ratio
22.05
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
15.09
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.50
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.34
EPS (ttm)Profit attributable to each share over the last twelve months.
0.85
Financials (FY)
Revenue (FY)
$15.12B−2.14%
Net Income (FY)
$1.47B+42.72%
Profit marginThe share of revenue left as profit after all costs and taxes.
10.76%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
1.92B
1-Year Return
−4.37%
Dividend and dates
Dividend
$0.84+4.48%
Ex-Dividend Date
August 12, 2026
Earnings Date
November 5, 2026estimated
Avg Volume
20.23M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

KVUE Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+12.45%
2025−15.85%
2024+3.12%
2023 (partial year)−18.44%

As of September 4, 2026.

KVUE Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$15.12B$1.47B9.7%
2024$15.46B$1.03B6.7%
2023$15.44B$1.66B10.8%
2022$14.95B$2.06B13.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$15.12B$8.79B$2.72B$1.47B9.7%
2024$15.46B$8.96B$2.63B$1.03B6.7%
2023$15.44B$8.64B$2.49B$1.66B10.8%
2022$14.95B$8.29B$2.69B$2.06B13.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

KVUE Dividend History

$0.83+2.0% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$0.633
2025$0.834+2.0%
2024$0.814+102.5%
2023$0.402

Most recent payment: $0.21 per share, ex-dividend August 12, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

KVUE Valuation vs Household & Personal Products Median

Median of 33 stocks
MetricKVUEHousehold & Personal Products medianvs median
P/E22.0522.050% above
P/S ratio2.341.08116% above
Profit margin10.76%0.00%10.8 pts above

Medians across 33 Household & Personal Products stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Kenvue Inc. (KVUE) is capitalised at $36.00B on the latest close. The company sits in the Consumer Defensive sector, in the Household & Personal Products industry. The company reports 21,780 employees.

KVUE last closed at $18.74 on September 4, 2026. That is −$0.21 (−1.11%) against the previous close. Over the past 52 weeks the price has ranged from $14.02 to $20.13. The latest close sits 33.67% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $15.12B. Against the prior fiscal year total of $15.46B, that is a change of −2.14%. Net income for the same year was $1.47B. That is +42.72% against the prior fiscal year. Profit margin runs at 10.76%. That is 10.8 percentage points above the Household & Personal Products median of 0%. Trailing earnings per share are 0.85.

Across the 4 fiscal years on file, revenue moves from $14.95B in 2022 to $15.12B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

KVUE trades at a trailing price-to-earnings ratio of 22.05. That is 0% above the Household & Personal Products median of 22.05. On forward earnings the ratio is 15.09. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.5. Measured against sales, the shares trade at 2.34 times revenue. On price-to-sales that is 115.64% above the Household & Personal Products median of 1.08. The medians here are taken across 33 Household & Personal Products companies that report the metric.

Over the trailing twelve months the price has returned −4.37%. Across 3 years the annualized return works out at −2.58%. Beta against the wider market is reported at 0.43. Daily returns over the trailing 3 years annualize to a volatility of 28.78%.

Growth & Income

The trailing dividend yield is 4.48%. That is 1.3 percentage points above the Household & Personal Products median yield of 3.13%. The indicated annual rate is $0.84 a share. The ex-dividend date on file is August 12, 2026. Dividends are recorded for 4 calendar years; 2026 shows 3 payments totalling $0.63 a share. The year before, 2025, totalled $0.83 a share.

2026 is still running; the price is +12.45% year to date. The strongest complete calendar year on file is 2024 at +3.12%; the weakest is 2025 at −15.85%.

Peer Comparison

Kenvue Inc. (KVUE) operates in the Household & Personal Products industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Kenvue Inc. KVUE $36.00B 22.1
The Procter & Gamble Company PG $340.13B 22.1
Unilever PLC UL $138.24B 21.8
Colgate-Palmolive Company CL $70.77B 35.0

The Household & Personal Products industry average P/E ratio is 22.1x. Kenvue Inc. trades at a P/E of 22.1.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Household & Personal Products Stocks

View all Household & Personal Products stocks →

Popular Consumer Defensive Stocks

View all Consumer Defensive stocks →

About Kenvue Inc.

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Visit website →